Table 2.
Patient characteristics.
| Variable | Missing Data (n) | |
|---|---|---|
| N | 1380 | |
| Age (Years), Median (IQR) | 71 (61–82) | 30 |
| Female Gender, n (%) | 598 (43.6) | 8 |
| Underlying Malignancy, n (%) | 4 | |
| Solid Malignancy | 1185 (86.1) | |
| Digestive and pancreas | 223 (18.8) | |
| Breast | 187 (15.8) | |
| Prostate | 175 (14.8) | |
| Lung | 172 (14.5) | |
| Kidney and bladder | 117 (9.9) | |
| Endometrium and ovary | 61 (5.1) | |
| Head and neck | 57 (4.8) | |
| Skin | 55 (4.6) | |
| Other | 138 (11.7) | |
| Hematologic Malignancy | 191 (13.9) | |
| Lymphoma | 73 (38.2) | |
| Chronic leukemia | 38 (19.9) | |
| Myeloma | 37 (19.4) | |
| Acute leukemia | 22 (11.5) | |
| Other | 21 (11.0) | |
| Time Since Diagnosis, n (%) | 122 | |
| <6 months | 236 (18.8) | |
| 6 months–5 years | 753 (59.9) | |
| >5 years | 269 (21.3) | |
| Disease Status, n (%) | 285 | |
| Complete remission | 270 (24.7) | |
| Partial remission | 354 (32.3) | |
| Uncontrolled malignancy | 471 (43.0) | |
| Metastatic, n (%) | 380 (47.1) | 573 |
| Specific Treatments in the Last 3 Months, n (%) | 134 | |
| Chemotherapy | 401 (32.2) | |
| Hormonotherapy | 127 (9.2) | |
| Radiotherapy | 73 (5.9) | |
| Surgery | 65 (5.2) | |
| Immunotherapy | 47 (3.8) | |
| Other | 17 (1.4) | |
| Poor Performance Status (>2), n (%) | 283 (24.3) | 213 |
| Patient Alone at Home, n (%) | 225 (27.7) | 569 |
| Home Nursing Service or Nursing Home Care, n (%) | 483 (37.3) | 85 |
IQR—inter-quartile range.